Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | G6PD | P11413 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516441 | 1.00 | L3MBTL1 (0.56) | L3MBTL1KDM4EMEN1KMT2APOLB | |
| Hydrochloric Acid SCHEMBL1496776 | 0.98 | L3MBTL1 (0.54) | L3MBTL1KDM4EMEN1KMT2APOLB | |
| SCHEMBL3884547 | 0.82 | KDM4E (0.42) | L3MBTL1KDM4EMEN1KMT2APOLB | |
| SCHEMBL744042 | 0.81 | EPHX2 (0.46) | L3MBTL1KDM4EMEN1KMT2APOLB | |
| Hydrochloric Acid SCHEMBL1496814 | 0.79 | KDM4E (0.50) | L3MBTL1KDM4EMEN1KMT2APOLB | |
| SCHEMBL2145798 | 0.79 | L3MBTL1 (0.50) | L3MBTL1POLBMAPK1MAPTCYP1A2 | |
| SCHEMBL3890599 | 0.78 | L3MBTL1 (0.53) | L3MBTL1POLBMAPK1MAPTALDH1A1 | |
| SCHEMBL30939139 | 0.78 | L3MBTL1 (0.53) | L3MBTL1POLBMAPK1MAPTALDH1A1 | |
| SCHEMBL2228010 | 0.78 | KDM4E (0.49) | L3MBTL1KDM4EMEN1KMT2APOLB | |
| SCHEMBL20886038 | 0.78 | KDM4E (0.52) | L3MBTL1KDM4EMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113737183-B | Selective copper etching solution | 湖北兴福电子材料有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-114350365-A | Etching solution for stably etching titanium nitride | 湖北兴福电子材料有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-113737183-A | Selective copper etching solution | 湖北兴福电子材料有限公司 | 2021-12-03 | — | — | CN | claimed |
| EP-4702021-A1 | COMPOUNDS CAPABLE OF MODULATING GPR65 | Pathios Therapeutics Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024224064-A1 | COMPOUNDS CAPABLE OF MODULATING GPR65 | Pathios Therapeutics Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| US-20240173307-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ABBVIE INC. | 2024-05-30 | — | — | US | disclosed |
| US-11939320-B2 | Modulators of the integrated stress pathway | ABBVIE INC. (US) | 2024-03-26 | — | — | US | disclosed |
| CN-112204006-B | Modulators of integrated stress pathways | 卡里科生命科学有限责任公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-3704089-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2023-07-19 | — | — | EP | disclosed |
| CN-113754679-B | Substituted pyrimidinediones and their use | 广东东阳光药业有限公司 | 2023-04-07 | — | — | CN | disclosed |
| WO-2022266458-A1 | 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |
| EP-0454831-B1 | Diazine derivatives as angiotensin II receptor antagonists | ICI PLC (GB) | 1994-08-03 | — | — | EP | disclosed |
| US-5126344-A | Angiotensin antagonists | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-06-30 | — | — | US | disclosed |
| EP-0454831-A1 | Diazine derivatives as angiotensin II receptor antagonists. | ICI PLC (GB) | 1991-11-06 | — | — | EP | disclosed |
| WO-1991007404-A1 | DIAZINE DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-05-30 | — | — | WO | disclosed |
| US-4897415-A | NEMATOCIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-01-30 | — | — | US | disclosed |
| CN-88100536-A | 2-imino--1,3-dithio-cyclobutane compounds and preparation method thereof and as the application of sterilant | — | 1988-09-14 | — | — | CN | disclosed |
| EP-0277091-A2 | 2-Imino-1,3-dithietanes, their preparation and use as pesticides | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-08-03 | — | — | EP | disclosed |
| EP-0008881-A1 | 1-Benzoyl-3-pyridinyl ureas, their use as insecticides, their preparation and formulations containing them | ELI LILLY AND COMPANY (US) | 1980-03-19 | — | — | EP | disclosed |
| US-4173639-A | INSECTICIDES | ELI LILLY AND COMPANY (US) | 1979-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240173307-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ATF4, ATF1, DDIT3 | L3MBTL1 1651/4885KDM4E 4646/4885MEN1 4714/4885 |
| US-11939320-B2 | Modulators of the integrated stress pathway | ATF4, ATF1, DDIT3 | L3MBTL1 1651/4885KDM4E 4646/4885MEN1 4714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.